Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intérêt de la rééducation érectile précoce Par Sildénafil après radiothérapie et Proctectomie Pour Cancer du Rectum : Essai contrôlé randomisé

NCT06123156 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT06123156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06123156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intérêt de la rééducation érectile précoce Par Sildénafil après radiothérapie et Proctectomie Pour Cancer du Rectum : Essai contrôlé randomisé
Lead sponsor
University Hospital, Rouen
Phase
Phase 3
Overall status
Recruiting
Start date
September 25, 2025
Completion date
February 28, 2030
Enrollment
188 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer